Frontal Fibrosing Alopecia (FFA)

This page is for you if you want to find out more about Frontal Fibrosing Alopecia.​

 

Frontal Fibrosing Alopecia is a type of scarring (permanent) hair loss that primarily affects the frontal hairline and eyebrows. It is most commonly seen in postmenopausal women, but can occur in men and younger individuals.

​

What Is Frontal Fibrosing Alopecia?

​

Frontal fibrosing alopecia (FFA) is a form of primary lymphocytic cicatricial (scarring) alopecia, meaning it involves inflammation that can permanently damage hair follicles.

 

It is considered a clinical variant of lichen planopilaris (LPP) and is now increasingly recognised in dermatology clinics worldwide as one of the more common forms of scarring alopecia.

 

The exact cause of FFA is not fully understood, but it is thought to involve a combination of immune, hormonal, and genetic factors.

 

The condition is characterised by:

 

• Progressive recession of the frontal and temporal hairline

• Loss of eyebrows (often an early sign)

• Gradual loss of visible follicular openings in affected areas

​

Unlike more common types of hair loss, FFA behaves differently. Once a hair follicle has been replaced by scar tissue, it is unlikely to produce hair again.

 

For many people, this is difficult to hear—particularly if they are learning about the condition for the first time.

However, the important and often overlooked point is this:

 

While lost follicles cannot be recovered, further loss can often be slowed or stabilised with appropriate treatment.

 

That is where early recognition becomes important.

Hair loss conditions and types of alopecia are often confused so it’s essential to get a diagnosis from an expert, not self-diagnose. 

 

What Is Actually Happening in Frontal Fibrosing Alopecia?

​

FFA is driven by an inflammatory process targeting the hair follicle, particularly at the level of the bulge region, which contains follicular stem cells essential for hair regeneration.

 

At a biological level, several key processes are involved:

​

1. Immune-Mediated Follicular Attack

​

• The immune system (particularly T lymphocytes) targets the hair follicle

• This leads to inflammation around the follicle

• Over time, this can damage the follicular stem cell niche

 

2. Progressive Follicular Damage

​

• As inflammation continues, follicles may be replaced with fibrous tissue

• Hair production gradually reduces and may stop in affected areas

 

This is why patients often notice:

 

• “My hairline is slowly moving back”

• “The skin looks smoother where hair used to be”

• ”My sideburns have gone”

• ”I wear a fringe now to hide it, but when the wind blows you can see my hair starts a long way back now”

• ”It’s like a band of smooth at the front, the rest is normal”

 

3. Loss of Follicular Immune Privilege (Proposed Mechanism)

​

Hair follicles are normally protected from immune attack.

 

In FFA:

 

• This protection appears to break down

• The follicle becomes vulnerable to inflammation

 

It Is a Patterned and Recognisable Process

 

FFA often follows a consistent pattern:

 

• Symmetrical recession of the frontal hairline

• Involvement of the temples

• Partial or complete loss of eyebrows

​

Other possible features:

 

• Loss of body hair

• Small facial bumps (papules)

• Redness or scaling around hair follicles in active stages

​

Not all patients experience symptoms such as itching or redness.

Some cases appear relatively “quiet” despite ongoing progression.

 

Many people first notice subtle changes:

 

• A slightly higher hairline

• Eyebrows thinning more than expected

• Changes that feel gradual, but persistent

 

If You Recognise These Changes — What Should You Do?

 

If this description feels familiar, it is important not to panic—but it is equally important not to delay.

 

Your first priority should be to seek assessment by a Dermatologist, ideally a dermatologist with a special interest in hair disorders. You can find a list here. 

 

FFA is a time-sensitive condition because inflammation can lead to permanent follicle loss.

Early assessment gives the best chance of limiting further progression.

 

Not all frontal hairline recession is FFA.

Conditions such as androgenetic alopecia can appear similar in early stages.

 

But distinguishing between them matters—because the management is completely different.

 

A structured assessment allows:

 

• Accurate diagnosis

• Identification of active inflammation

• Early intervention where appropriate

 

Who Does Frontal Fibrosing Alopecia Affect — and When Does It Start?

​

Typical Demographic

​

• Most commonly affects women over 50

• Frequently associated with postmenopausal status

​

However:

 

• Increasingly recognised in younger women

• Can occur in men (often underdiagnosed)

 

Onset and Progression

​

• Usually gradual

• Hairline recession develops over months to years

• Eyebrow loss may occur early

​

Patients often describe:

 

• “It’s been slowly changing, not suddenly falling out”

​

 

A Chronic Condition

​

FFA is typically long-term and variable.

 

In some individuals:

 

• It progresses steadily
  In others:

• It stabilises over time

​

At present, it is not possible to predict this with certainty in an individual patient.

 

How Is Frontal Fibrosing Alopecia Diagnosed?

​

Diagnosis should be made by a Dermatologist.

 

1. Clinical History

​

Key features:

 

• Gradual hairline recession

• Eyebrow loss

• Symptoms such as itching, burning, or tenderness

 

2. Pattern Recognition

​

Typical findings:

 

• Band-like frontal recession

• Smooth, pale skin

• Reduced or absent follicular openings

​

3. Trichoscopy (Scalp Dermoscopy)

​

One of the most useful tools.

 

Common findings:

 

• Loss of follicular openings

• Perifollicular redness and scaling

• Reduced follicle density

 

4. Skin Biopsy (If Needed)

​

Used when diagnosis is uncertain.

 

Findings typically include:

 

• Lymphocytic inflammation

• Fibrosis replacing follicles

 

5. Blood Tests

​

Used to exclude other causes, not to diagnose FFA.

 

Diagnostic Nuance

​

In early stages, distinguishing FFA from other forms of hair loss can be challenging.

This is one of the reasons specialist assessment is important.

​

Key Point

​

FFA is diagnosed through:

 

• Clinical pattern

• Trichoscopy

• ± biopsy

​

Getting this right early is important, because it directly affects management.

​

The Emotional Impact — and Why It Matters

​

For many people, the most difficult part of FFA is not just the diagnosis itself, but what it represents.

 

Changes to the hairline and eyebrows can:

 

• Affect how you recognise yourself

• Change how you feel in social or professional settings

• Create a sense of loss that can be difficult to put into words

​

These reactions are not superficial—they are a normal and understandable response to a visible change in appearance.

 

Some people find it helpful to speak with a professional experienced in supporting individuals adjusting to changes in appearance, such as a clinical psychologist.

Others may prefer to talk to family, friends, or support groups.

 

There is no single “right” way to respond—but it is worth recognising that support exists, and you do not have to navigate this alone.

 

Which Treatments for Frontal Fibrosing Alopecia Actually Work?

​

There is currently no treatment that reverses established scarring.

 

However, treatment aims to suppress inflammation and stabilise the condition, although the degree of response varies between individuals.

 

Treatment can:

 

• Reduce inflammation

• Slow progression

• Help preserve remaining hair

​

This is where early intervention makes a meaningful difference.

 

Treatments Targeting Inflammation

​

Topical Corticosteroids

​

• Reduce local inflammation

• Often used in early or active disease

 

Topical Calcineurin Inhibitors

​

• Anti-inflammatory without steroid-related skin thinning

• Often used for maintenance

 

Intralesional Steroid Injections

​

• Delivered directly into affected areas

• Commonly used in specialist settings

​

Systemic Treatments

 

Hydroxychloroquine

​

• Widely used in inflammatory hair conditions

• May help reduce disease activity

 

Oral Anti-Inflammatory or Immunomodulatory Treatments

 

Examples:

 

• Doxycycline

• Methotrexate (selected cases)

 

5-Alpha Reductase Inhibitors

 

(e.g. finasteride, dutasteride)

 

• Increasing evidence for stabilisation in some patients

 

Adjunctive Options

 

Platelet-Rich Plasma (PRP)

​

• Emerging evidence

• May support remaining follicles

• Does not reverse scarring

 

Low-Level Laser Therapy (LLLT)

 

• Limited evidence in FFA specifically

• May be used as supportive therapy

 

A Realistic but Reassuring Perspective

 

It is important to be clear, but also balanced.

 

FFA is not a condition where:

 

• Hair can be fully restored once lost

​

But it is a condition where:

 

• Progression can often be slowed

• Remaining hair can be protected

• A thoughtful, early approach can make a meaningful difference over time

 

Which Treatment Is Right for You?

 

Management depends on:

 

• Whether the disease is active

• How much hair has already been affected

• Your personal goals

 

A Practical Framework

​

Most patients follow a structure such as:

 

• Foundation: anti-inflammatory treatment

• Escalation: systemic therapy if disease is active

• Support: adjunctive options where appropriate

• Cosmetic strategies: where needed

 

Ongoing Monitoring

​

Ongoing follow-up is usually required to:

 

• Assess whether the condition is active

• Monitor response to treatment

• Adjust management where needed

​

This is an important part of care, as disease activity can change over time.

​

Advanced Considerations

​

Once the condition is stable:

 

• Hair transplantation may be considered by some surgeons in selected cases where disease is not active - but this is not common

• Eyebrow restoration or cosmetic camouflage may help

 

Timing is important—intervention is only considered when inflammation is controlled.

 

Key Point

​

Frontal fibrosing alopecia is different from more common hair loss conditions:

 

• It is inflammatory

• It can be scarring

• It requires early, specialist assessment

​

If there is one takeaway, it is this:

 

Early recognition and timely assessment give you the best chance of protecting the hair you still have.

 

In Summary

​

Frontal fibrosing alopecia is an inflammatory, scarring hair loss condition.

Treatment focuses on slowing progression and preserving remaining hair—because once follicles are lost, they cannot be recovered.

Early diagnosis and specialist care are key.

​

Frequently Asked Questions

​

Can hair grow back in frontal fibrosing alopecia?

Hair regrowth where follicles have been lost is unfortunately not possible. Treatment focuses on preventing further loss.

 

Is frontal fibrosing alopecia the same as female pattern hair loss or Androgenetic Alopecia?

No. FFA is an inflammatory scarring condition, whereas female pattern hair loss is non-scarring and driven by different biological mechanisms. They are entirely different disease processes and need different treatment. 

 

Is frontal fibrosing alopecia the same as Alopecia Areata?

No. FFA is an inflammatory scarring condition, whereas Alopecia Areata is an autoimmune disease presenting with patches of hair loss or extensive hair loss or total loss (patchy Alopecia areata/ Alopecia totalis / Alopecia Universalis). Hair loss does not follow the same pattern on the scalp as Frontal Fibrosing and the trichoscopic microscopic findings are very different. 

 

How quickly does FFA progress?

Progression varies between individuals. Some cases progress slowly and stabilise, while others may be more active.

 

Is eyebrow loss always permanent?

If follicles have been significantly damaged, regrowth may be limited. Early treatment may help preserve remaining eyebrow hair.

​

Do I need ongoing treatment?

Many patients require ongoing monitoring and, in some cases, maintenance treatment to keep the condition stable.

 

Authored by: Dr Gwen Adey BDS MFDS RCS

Date first published: 12/04/26